Pilocarpine Hydrochloride Ophthalmic Solution — FDA Drug Shortage
The FDA lists a drug shortage record for Pilocarpine Hydrochloride Ophthalmic Solution (ophthalmic solution) from AbbVie Inc. with status To Be Discontinued. The shortage was first posted on Mar 24, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- AbbVie Inc.
- Package NDC
- 0074-7098-04
- Dosage Form
- Ophthalmic Solution
- Presentation
- Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04)
- Initial Posting
- Mar 24, 2026